J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Subscribe To Our Newsletter & Stay Updated